Global liposome research in the period of 1995–2014: a bibliometric analysis
暂无分享,去创建一个
[1] Yuh-Shan Ho,et al. A historical review and bibliometric analysis of research on estuary pollution. , 2012, Marine pollution bulletin.
[2] Francisco Herrera,et al. Science mapping software tools: Review, analysis, and cooperative study among tools , 2011, J. Assoc. Inf. Sci. Technol..
[3] A. Pritchard,et al. Statistical bibliography or bibliometrics , 1969 .
[4] V. P. Whittaker,et al. Negatively Stained Lipoprotein Membranes , 1963, Nature.
[5] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[6] Andreas Zimmer,et al. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[7] Chaomei Chen,et al. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace , 2012, Expert opinion on biological therapy.
[8] J. Lovrić,et al. Nanotherapeutics in the EU: an overview on current state and future directions , 2014, International journal of nanomedicine.
[9] David Arthur,et al. Mapping publication status and exploring hotspots in a research field: chronic disease self-management. , 2014, Journal of advanced nursing.
[10] M. Yeh,et al. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy , 2011, International journal of nanomedicine.
[11] Meen Chul Kim,et al. Emerging trends and new developments in regenerative medicine: a scientometric update (2000 – 2014) , 2014, Expert opinion on biological therapy.
[12] Fernando R. Mazarrón,et al. Bibliometric analysis of research activity in the “Agronomy” category from the Web of Science, 1997–2011 , 2013 .
[13] M. Kamal,et al. Nanotechnology-based approaches in anticancer research , 2012, International journal of nanomedicine.
[14] 魏屹东,et al. Scientometrics , 2018, Encyclopedia of Big Data.
[15] Yang Liu,et al. A bibliometric analysis of academic publication and NIH funding , 2013, J. Informetrics.
[16] Chun-Ping Huang,et al. Bibliometric Analysis of Obstructive Sleep Apnea Research Trends , 2009, Journal of the Chinese Medical Association.
[17] V. Torchilin,et al. Current trends in the use of liposomes for tumor targeting. , 2013, Nanomedicine.
[18] Sisira Edirippulige,et al. Telemedicine - A bibliometric and content analysis of 17, 932 publication records , 2014, Int. J. Medical Informatics.
[19] Giulio Caracciolo,et al. Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[20] Jing Zhang,et al. Assessment of world aerosol research trends by bibliometric analysis , 2008, Scientometrics.
[21] Qiang Wang,et al. A bibliometric analysis of research on the risk of engineering nanomaterials during 1999-2012. , 2014, The Science of the total environment.
[22] Robert Langer,et al. Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[23] Xinli Liu,et al. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. , 2011, Molecular pharmaceutics.
[24] John C Kraft,et al. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. , 2014, Journal of pharmaceutical sciences.
[25] Xiaodong Yang,et al. The highly-cited Electrocardiogram-related articles in science citation index expanded: characteristics and hotspots. , 2014, Journal of electrocardiology.
[26] F. López-Muñoz,et al. A Bibliometric Study on Second-generation Antipsychotic Drugs in the Asia–Pacific Region , 2014 .
[27] Pedro Ramos-Cabrer,et al. Liposomes and nanotechnology in drug development: focus on neurological targets , 2013, International journal of nanomedicine.
[28] Mojca Pavlin,et al. Electrotransfection and Lipofection Show Comparable Efficiency for In Vitro Gene Delivery of Primary Human Myoblasts , 2014, The Journal of Membrane Biology.
[29] Hong Song,et al. Research Trends in Non Point Source during 1975-2010 , 2012 .
[30] A. Bangham,et al. NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. , 1964, Journal of molecular biology.
[31] Y. Reshetnyak,et al. pHLIP®-mediated delivery of PEGylated liposomes to cancer cells. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[32] Yoshihiko Araki,et al. Liposomes and nanotechnology in drug development: focus on ocular targets , 2012, International journal of nanomedicine.
[33] J. Lucy,et al. Action of Saponin on Biological Cell Membranes , 1962, Nature.
[34] K. Brown,et al. From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker. , 2013, Bioconjugate chemistry.
[35] M. Yeh,et al. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells , 2011, International journal of nanomedicine.
[36] Ashish Ranjan Sharma,et al. Recent Trends of Polymer Mediated Liposomal Gene Delivery System , 2014, BioMed research international.
[37] M. Yeh,et al. Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery , 2013, International journal of nanomedicine.